LGALS3BP and cancer: Interestingly, while we observed a similar amount of total secreted LGALS3BP in the two groups, we found a significant increase (P = 0.03) of vesicular‐associated LGALS3BP expression in cancer samples compared to healthy donors, as calculated by the average percentage of vesicular on total circulating LGALS3BP (Fig. 1B).